X0508 4 2023-07-25 0001505497 BioRestorative Therapies, Inc. BRTX 0001756228 ALSTODT LANCE 40 MARCUS DRIVE MELVILLE NY 11747 true true true President, CEO, COB false Common Stock 2023-07-25 4 P 0 4200 2.44 A 184418 D Stock Option 5.08 2031-03-18 Common Stock 293479 293479 D Stock Option 5.08 2031-11-04 Common Stock 42059 42059 D Stock Option 2.91 2033-02-17 Common Stock 106762 106762 D This transaction was executed in multiple trades at prices ranging from $2.41 to $2.47 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. Includes 48,912 shares received pursuant to an unvested restricted stock unit grant. Such shares vest on March 18, 2024. The option vests and becomes exercisable to the extent of 146,740 shares on March 18, 2021, 36,684 shares on November 4, 2021 and 110,055 shares in six nearly equal quarterly installments beginning December 18, 2021 and continuing every three months thereafter until fully vested. The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 and 21,029 shares in eight nearly equal quarterly installments beginning November 4, 2022 and continuing every three months thereafter until fully vested. The option vests and becomes exercisable to the extent of 53,381 shares on February 17, 2023 and 53,381 shares in eight nearly equal quarterly installments beginning February 17, 2024 and continuing every three months thereafter until fully vested. /s/ Lance Alstodt 2023-07-25